RXO · RXO, Inc. · Stock research

Current Thesis

The leg an investor is buying in RXO has a mechanical shape: an asset-light broker carrying almost no fixed cost absorbs a truckload spot squeeze, so a few cents of linehaul movement becomes a step-change in EBITDA. Q2 proved the mechanism — adjusted EBITDA of $40M against a $27–37M guide, revenue $1.774B versus $1.603B consensus, adjusted EPS $0.06 versus $0.03 (release, 2026-08-06). What the tape is now pricing is the input stalling. DAT's week-34 dry van reading put spot linehaul at $2.21 per mile, down $0.04 week-over-week and a fourth consecutive weekly decline, after $2.25 for the week ended 2026-08-14. DAT's own 35-day projection, published 2026-08-17, put the line at $2.24 per mile in mid-September inside a ±$0.08 band. The rate has undercut its forecaster's mid-September centre roughly a month early.

Price followed. The $24 May–June shelf went on the 2026-08-14 weekly close of $23.52; the next week closed $22.54 (2026-08-21); the 2026-08-24 session closed $21.28, roughly a dollar above the 2026-08-06 print-day close of $20.24 that forms the floor of the post-earnings range. RSI(14) read 45.7 against 59.0 three sessions earlier — the bounce rolled over mid-range without retesting the shelf it lost. The shares sit 27.4% below the $29.30 52-week high, with a three-month price change of -14.9%.

The narrative is saturated. Consensus was $24.47 across 21 analysts on 2026-08-13, $24.47 across 21 on 2026-08-21, and $24.47 across 21 on 2026-08-25 — 5 Strong Buy / 2 Buy / 11 Hold / 1 Sell / 2 Strong Sell, range $13 to $35, median $23. Six actions landed inside two sessions on 2026-08-06–07 (UBS $23, Citi $23 from $30, Truist $28 from $30, TD Cowen $17.50 from $19, Stifel $31, Citizens upgrading with a $30 target). Nothing has been recorded since Wells Fargo maintained Hold at $22 on 2026-08-14 — seven sessions of static, two-sided, fully-distributed coverage while the price fell through the middle of it. That is late-cycle positioning, not a fresh bid. A weekly close under the $20.24 post-print floor would date the flip from saturated to dead.

Bullish and bearish views on RXO, Inc.

The model's bull view on RXO, Inc. (RXO), in brief: Q2 2026 adjusted EBITDA $40M against a $27–37M guide, on revenue of $1.774B versus $1.603B consensus and adjusted EPS $0.06 versus $0.03 (release, 2026-08-06). The bear view: The rate engine has rolled for four straight weeks. Both cases follow in full.

Bull Case

• Q2 2026 adjusted EBITDA $40M against a $27–37M guide, on revenue of $1.774B versus $1.603B consensus and adjusted EPS $0.06 versus $0.03 (release, 2026-08-06). The operating leverage is real and recent: Q1 2026 adjusted EBITDA was $6M.
• The Q3 guide of $35–45M brackets the $40M just delivered, with brokerage volume guided to low-to-mid single-digit YoY growth and gross profit per load up sequentially again (2026-08-06 call).
• July truckload gross profit per load ran +20% YoY, disclosed on the 2026-08-06 call from outside the reported quarter, after Q2's +11% sequential gain on a 900bp sequential rise in spot mix to 42%.
• Mix kept shifting after the quarter closed. CSO Jared Weisfeld told Deutsche Bank's Chicago Industrials Summit on 2026-08-11 that spot ran roughly 50% of brokerage mix in July, with repricing approaching 20% by late summer.
• Capacity is structurally thinner than a year ago. DAT's 2026-08-17 report showed van load-to-truck at 9.98 versus 5.77 a year earlier, truck posts -26.4% YoY, load posts +27.2% YoY, and linehaul 38.4% above the year-ago week and 25.8% above the nine-year seasonal average of $1.78. Week 34 held the ratio near 9.9 even as the rate slipped.
• The short base is large relative to a thin float: 14,486,044 shares at the 2026-07-31 settlement, 8.85% of float, 6.6 days to cover, down 2.13% from 14,801,430 at 2026-07-15.
• The mean sell-side target of $24.47 sits above the 2026-08-24 close of $21.28, and the high end of the range ($35, BMO) has not been withdrawn.

Bear Case

• The rate engine has rolled for four straight weeks. $2.21/mile in week 34, down $0.04, after $2.25 (-1.3%) for the week ended 2026-08-14. The bull leg was never about the level; it was about the direction, and the direction has changed.
• Spot no longer sits above contract. DAT's monthly release published 2026-08-11 showed July van spot and contract linehaul both at $2.39. A broker's gross profit per load compresses when spot runs through contract, and that spread is now zero on the last published monthly reading.
• The forecaster's own floor is close. The ±$0.08 band around $2.24 puts the lower edge at $2.16 — three cents from the week-34 print, with three weeks still to run to the mid-September horizon.
• Cash is going out the door while the cycle runs. Q2 2026 disclosure carried a ~$70M working-capital drag and 4.1x bank-adjusted net leverage; an up-cycle consumes working capital at this model, so leverage improves last, not first.
• Coverage is majority-neutral-to-negative. Of 21 analysts, 11 Hold, 1 Sell, 2 Strong Sell; the low target is $13 and TD Cowen sits at $17.50 after downgrading to Sell on 2026-07-28 on broker-liability exposure.
• Litigation discounts the whole cohort. The $604M Lipe v. Lupus Superior verdict sits with C.H. Robinson, not RXO, but the multiple applied to asset-light brokers moves with its post-trial path. RXO's only publicly quantified figure against that exposure is casualty spend of roughly $15–20M a year with a $5M per-occurrence deductible.
• There is no company-reported checkpoint for two months. The last RXO-sourced number is the 2026-08-06 release; the next is the Q3 print, estimated late October. Everything between is third-party rate data and beta.

Setup & Price Structure

The structure is a broken shelf with no base under it. The $24 May–June consolidation floor was lost on the 2026-08-14 weekly close of $23.52 and has not been retested. The 2026-08-21 close of $22.54 marked the high-water mark of the rebound attempt; the 2026-08-24 close of $21.28 gave it back and then some. The operative level below is the 2026-08-06 print-day close of $20.24, which is where the market marked the stock after a quarter that beat both revenue and EBITDA guidance — a level set on good news, which makes losing it informative rather than noisy.

Momentum confirms the failure without adding much: RSI(14) at 45.7 on 2026-08-24 against 59.0 on 2026-08-21. The oscillator ran into the upper half of the post-print range and turned before clearing it. No higher low has formed since 2026-08-06.

Crowding and positioning observables, stated as observables: 8.85% of float short at the 2026-07-31 settlement with days-to-cover at 6.6, down from 10.7 at 2026-07-15 — the short base shrank on rising volume rather than being squeezed out. Sell-side flow clustered into two sessions (2026-08-06–07, six actions) and then stopped; nothing since 2026-08-14. The mean target has been frozen at $24.47 across three separate readings while the price fell roughly $1.26 over the last two sessions of that window. Beta near 1.9 means index and sector moves land amplified; the February 2026 session in which the shares fell 20.45% is the reference point for how that behaves on a bad tape.

Catalyst Calendar (next 30 days)

• 2026-08-26 (est.) — Exchange short-interest publication for the 2026-08-14 settlement.
• ~2026-08-31 (est.) — DAT weekly dry van report for week 35. Whether the four-week decline extends and whether linehaul approaches the $2.16 lower band edge.
• ~2026-08-31 (est.) — RXO Curve report covering Q2 2026 truckload spot rates. The company's own cycle index; the edition live on rxo.com as of 2026-08-21 still carried Q1 (all-in index 129, spot +16.5% YoY, contract +2.4% YoY, measured through mid-May).
• ~2026-09-01 (est.) — Post-trial and appellate filings in Lipe v. Lupus Superior (Dallas County). C.H. Robinson has said it will appeal; whether the trial court enters, reduces or vacates the $604M verdict sets the liability benchmark the broker cohort is discounted against.
• ~2026-09-10 (est.) — DAT monthly rate release for August 2026. The July edition, published 2026-08-11, put van spot and contract linehaul both at $2.39; this checks whether spot has slipped below contract.
• ~2026-09-15 (est.) — Horizon date of DAT's 35-day forecast of $2.24/mile ±$0.08. A print below $2.16 puts the cycle under its own forecaster's floor.
• ~2026-09-15 (est.) — D.C. Circuit oral argument in Rivera Lujan v. FMCSA on the non-domiciled CDL rule, in force since 2026-03-16. It is the regulatory leg of the capacity-tightness argument.
• ~2026-10-29 (est.) — Q3 2026 print. Outside the window and the only company-reported checkpoint until then: the $35–45M adjusted EBITDA guide, whether the ~$70M working-capital drag reverses, and whether bank-adjusted net leverage moves off 4.1x.

What Would Change Our Mind

The structure that mattered is already gone: the $24 May–June shelf was lost on the 2026-08-14 weekly close of $23.52 and has not been reclaimed, and the rebound failed at $22.54 on 2026-08-21. What remains is the post-print floor. A weekly close below $20.24 takes out the level the market set on 2026-08-06 after a quarter that beat on revenue and EBITDA, and ends the recovery leg as a tradeable structure rather than merely bending it.

On the fundamental side, the specific datapoint that would break the argument is DAT dry van spot linehaul printing under $2.16 — the lower edge of DAT's own mid-September band — before the ~2026-09-15 horizon. The week-34 reading of $2.21 leaves three cents of room. A second one is the ~2026-09-10 DAT monthly showing August van spot linehaul below contract after both printed $2.39 in July, which compresses gross profit per load directly. On the company side, Q3 adjusted EBITDA landing below the $35–45M guide floor at the ~2026-10-29 print, or bank-adjusted net leverage above 4.1x with the ~$70M working-capital drag unreversed.

What would rebuild the case: a weekly close back above $23.52 with linehaul turning up week-over-week, or a fresh upgrade breaking the seven-session silence in the sell-side tape since 2026-08-14 and moving the frozen $24.47 mean.

Correlation Notes

• Trades with the asset-light brokerage cohort — C.H. Robinson, Landstar, XPO — and with truckload carriers Saia and ArcBest on sector days. The February 2026 session that took RXO down 20.45% also moved Landstar -15.6% and Expeditors -13.18%.
• The single strongest driver is the DAT dry van spot linehaul series, published weekly on Mondays and monthly around the 10th. Gross profit per load is a spread business, so the spot-minus-contract gap matters more than the absolute rate; both printed $2.39 in July.
• Litigation beta is shared, not idiosyncratic. The Lipe v. Lupus Superior docket moves the broker multiple as a group regardless of which name is a party.
• Beta near 1.9 means index drawdowns transmit amplified. Company-specific progress in the rate data can be entirely overwhelmed by a broad industrials move.
• The regulatory leg — the FMCSA non-domiciled CDL rule in force since 2026-03-16 — is a supply-side input shared with every truckload name; a D.C. Circuit ruling for petitioners would loosen the driver-exit path across the sector.